APA

Nickoloff B. J., Lewinsohn D. M., Butcher E. C., Krensky A. M. & Clayberger C. (19880204). Recombinant gamma interferon increases the binding of peripheral blood mononuclear leukocytes and a Leu-3+ T lymphocyte clone to cultured keratinocytes and to a malignant cutaneous squamous carcinoma cell line that is blocked by antibody against the LFA-1 molecule. : The Journal of investigative dermatology.

Chicago

Nickoloff B J, Lewinsohn D M, Butcher E C, Krensky A M and Clayberger C. 19880204. Recombinant gamma interferon increases the binding of peripheral blood mononuclear leukocytes and a Leu-3+ T lymphocyte clone to cultured keratinocytes and to a malignant cutaneous squamous carcinoma cell line that is blocked by antibody against the LFA-1 molecule. : The Journal of investigative dermatology.

Harvard

Nickoloff B. J., Lewinsohn D. M., Butcher E. C., Krensky A. M. and Clayberger C. (19880204). Recombinant gamma interferon increases the binding of peripheral blood mononuclear leukocytes and a Leu-3+ T lymphocyte clone to cultured keratinocytes and to a malignant cutaneous squamous carcinoma cell line that is blocked by antibody against the LFA-1 molecule. : The Journal of investigative dermatology.

MLA

Nickoloff B J, Lewinsohn D M, Butcher E C, Krensky A M and Clayberger C. Recombinant gamma interferon increases the binding of peripheral blood mononuclear leukocytes and a Leu-3+ T lymphocyte clone to cultured keratinocytes and to a malignant cutaneous squamous carcinoma cell line that is blocked by antibody against the LFA-1 molecule. : The Journal of investigative dermatology. 19880204.